LED Medical Inc. announces VELscope Vx Results from REALITY Review

LED Medical Diagnostics Inc. is pleased to announce that the VELscope Vx Enhanced Oral Assessment System has received a REALITY’S CHOICES rating of 4.5 stars (out of a possible 5).

Burnaby, British Columbia—March 05, 2014—LED Medical Diagnostics Inc. (“LED Medical” or the “Company”) is pleased to announce that the VELscope Vx Enhanced Oral Assessment System has received a REALITY’S CHOICES rating of 4.5 stars (out of a possible 5).

REALITY’s evaluators were tasked with implementing the VELscope Vx system into their practices and evaluating its features, including clinical utility, ease-of-operation, camera system use, and marketing materials.

RELATED | Clinical study concludes that VELscope technology improves clinical decision making

The VELscope Vx device was very well received by the evaluators and the following strengths were highlighted:

• Noninvasive
• Requires no rinses
• Solid research base
• Well received by appreciative patients
• Short examination time
• Convenient cordless design
• Easy-to-attach camera system enables clinicians to easily record images and monitor mucosal lesions
• Clinical utility

ADDITIONAL READING |Breaking it down: Oral cancer screenings, periodontal assessments enhance the Ritz-Carlton experience

“We are very pleased to receive a standout rating on the REALITY evaluation,” states Dr. David Gane, CEO of LED Medical. “In addition to acknowledging the VELscope Vx device as an improvement over its predecessor on many features, the REALITY evaluators also were able to detect mucosal lesions invisible to the naked eye and provide their patients with suitable follow-up.”

According to REALITY: “Slightly more than half (57%) of evaluators found lesions that were not visible without using it, while the remaining 43% did not find any lesions during the evaluation period. Of those evaluators who found lesions, half decided to put them on watch and check them again in several months, 25% reported that no lesions were found to be malignant, and 25% found at least one malignant lesion. One evaluator found three areas of concern and referred to an oral surgeon. One area that was biopsied was malignant and required extensive surgery.”

“We were pleased to learn that VELscope® Vx technology helped the evaluators in the discovery of potentially pre-cancerous and cancerous tissues,” states Dr. Gane. “The VELscope Vx device is an imaging modality which is extremely sensitive to tissue changes, and its use in everyday practice can provide timely information to dentists and hygienists to enable earlier detection of abnormal tissues and provide better outcomes for patients.”

More in Oral Cancer